vs
Side-by-side financial comparison of Paylocity Holding Corp (PCTY) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $387.0M, roughly 1.6× Paylocity Holding Corp). Royalty Pharma plc runs the higher net margin — 34.4% vs 13.0%, a 21.5% gap on every dollar of revenue. On growth, Paylocity Holding Corp posted the faster year-over-year revenue change (11.3% vs 4.8%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 2.7%).
Paylocity Holding Corporation is an American provider of cloud-based payroll, , spend management, and human capital management (HCM) software.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
PCTY vs RPRX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $387.0M | $622.0M |
| Net Profit | $50.2M | $214.2M |
| Gross Margin | 72.9% | — |
| Operating Margin | 18.2% | 62.4% |
| Net Margin | 13.0% | 34.4% |
| Revenue YoY | 11.3% | 4.8% |
| Net Profit YoY | 34.0% | 2.9% |
| EPS (diluted) | $0.92 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $387.0M | $622.0M | ||
| Q3 25 | $378.9M | $609.3M | ||
| Q2 25 | $369.9M | $578.7M | ||
| Q1 25 | $421.1M | $568.2M | ||
| Q4 24 | $347.7M | $593.6M | ||
| Q3 24 | $333.1M | $564.7M | ||
| Q2 24 | $324.7M | $537.3M | ||
| Q1 24 | $366.8M | $568.0M |
| Q4 25 | $50.2M | $214.2M | ||
| Q3 25 | $48.0M | $288.2M | ||
| Q2 25 | $48.6M | $30.2M | ||
| Q1 25 | $91.5M | $238.3M | ||
| Q4 24 | $37.5M | $208.2M | ||
| Q3 24 | $49.6M | $544.0M | ||
| Q2 24 | $48.8M | $102.0M | ||
| Q1 24 | $85.3M | $4.8M |
| Q4 25 | 72.9% | — | ||
| Q3 25 | 73.9% | — | ||
| Q2 25 | 73.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 72.6% | — | ||
| Q3 24 | 74.4% | — | ||
| Q2 24 | 74.0% | — | ||
| Q1 24 | 77.8% | — |
| Q4 25 | 18.2% | 62.4% | ||
| Q3 25 | 19.6% | 70.1% | ||
| Q2 25 | 17.9% | 36.3% | ||
| Q1 25 | 30.2% | 94.0% | ||
| Q4 24 | 13.4% | 60.9% | ||
| Q3 24 | 19.3% | — | ||
| Q2 24 | 19.4% | 50.2% | ||
| Q1 24 | 29.0% | -13.0% |
| Q4 25 | 13.0% | 34.4% | ||
| Q3 25 | 12.7% | 47.3% | ||
| Q2 25 | 13.1% | 5.2% | ||
| Q1 25 | 21.7% | 41.9% | ||
| Q4 24 | 10.8% | 35.1% | ||
| Q3 24 | 14.9% | 96.3% | ||
| Q2 24 | 15.0% | 19.0% | ||
| Q1 24 | 23.3% | 0.8% |
| Q4 25 | $0.92 | $0.49 | ||
| Q3 25 | $0.86 | $0.67 | ||
| Q2 25 | $0.87 | $0.07 | ||
| Q1 25 | $1.61 | $0.55 | ||
| Q4 24 | $0.66 | $0.46 | ||
| Q3 24 | $0.88 | $1.21 | ||
| Q2 24 | $0.85 | $0.23 | ||
| Q1 24 | $1.50 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $162.5M | $618.7M |
| Total DebtLower is stronger | $81.3M | $9.0B |
| Stockholders' EquityBook value | $1.1B | $9.7B |
| Total Assets | $7.0B | $19.6B |
| Debt / EquityLower = less leverage | 0.07× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $162.5M | $618.7M | ||
| Q3 25 | $165.2M | $938.9M | ||
| Q2 25 | $398.1M | $631.9M | ||
| Q1 25 | $477.8M | $1.1B | ||
| Q4 24 | $482.4M | $929.0M | ||
| Q3 24 | $778.5M | $950.1M | ||
| Q2 24 | $401.8M | $1.8B | ||
| Q1 24 | $492.7M | $843.0M |
| Q4 25 | $81.3M | $9.0B | ||
| Q3 25 | $81.3M | $8.9B | ||
| Q2 25 | $162.5M | $8.0B | ||
| Q1 25 | $243.8M | $7.6B | ||
| Q4 24 | $325.0M | $7.6B | ||
| Q3 24 | $325.0M | $7.6B | ||
| Q2 24 | $0 | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $1.1B | $9.7B | ||
| Q3 25 | $1.1B | $9.6B | ||
| Q2 25 | $1.2B | $9.5B | ||
| Q1 25 | $1.2B | $9.8B | ||
| Q4 24 | $1.2B | $10.3B | ||
| Q3 24 | $1.1B | $10.3B | ||
| Q2 24 | $1.0B | $9.8B | ||
| Q1 24 | $1.1B | $9.9B |
| Q4 25 | $7.0B | $19.6B | ||
| Q3 25 | $4.2B | $19.3B | ||
| Q2 25 | $4.4B | $18.3B | ||
| Q1 25 | $5.2B | $17.6B | ||
| Q4 24 | $5.3B | $18.2B | ||
| Q3 24 | $4.0B | $18.0B | ||
| Q2 24 | $4.2B | $17.7B | ||
| Q1 24 | $5.0B | $16.1B |
| Q4 25 | 0.07× | 0.92× | ||
| Q3 25 | 0.07× | 0.93× | ||
| Q2 25 | 0.13× | 0.84× | ||
| Q1 25 | 0.20× | 0.78× | ||
| Q4 24 | 0.28× | 0.74× | ||
| Q3 24 | 0.29× | 0.74× | ||
| Q2 24 | 0.00× | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $117.0M | $827.1M |
| Free Cash FlowOCF − Capex | $113.6M | — |
| FCF MarginFCF / Revenue | 29.4% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 2.33× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $461.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $117.0M | $827.1M | ||
| Q3 25 | $86.5M | $702.6M | ||
| Q2 25 | $86.6M | $364.0M | ||
| Q1 25 | $186.0M | $596.1M | ||
| Q4 24 | $54.2M | $742.5M | ||
| Q3 24 | $91.5M | $703.6M | ||
| Q2 24 | $79.9M | $658.2M | ||
| Q1 24 | $167.5M | $664.6M |
| Q4 25 | $113.6M | — | ||
| Q3 25 | $82.7M | — | ||
| Q2 25 | $81.1M | — | ||
| Q1 25 | $183.7M | — | ||
| Q4 24 | $51.2M | — | ||
| Q3 24 | $89.1M | — | ||
| Q2 24 | $73.6M | — | ||
| Q1 24 | $162.0M | — |
| Q4 25 | 29.4% | — | ||
| Q3 25 | 21.8% | — | ||
| Q2 25 | 21.9% | — | ||
| Q1 25 | 43.6% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 26.8% | — | ||
| Q2 24 | 22.7% | — | ||
| Q1 24 | 44.2% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 1.5% | — |
| Q4 25 | 2.33× | 3.86× | ||
| Q3 25 | 1.80× | 2.44× | ||
| Q2 25 | 1.78× | 12.06× | ||
| Q1 25 | 2.03× | 2.50× | ||
| Q4 24 | 1.45× | 3.57× | ||
| Q3 24 | 1.84× | 1.29× | ||
| Q2 24 | 1.64× | 6.45× | ||
| Q1 24 | 1.96× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PCTY
| Recurring Fees | $370.1M | 96% |
| Implementation Services And Other | $16.9M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
